Last updated 2026-07-26
- Acquired by Qiagen for $80M, May 2025
Total raised
—
Last: Undisclosed Round 2024-04
Stage
Acquired
Founded
2014
Headcount
55
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Genoox is a healthcare and technology company focused on enhancing the accessibility of clinical genetic sequencing. Its cloud-based advanced framework, including purpose-built applications, manages the entire genetic sequencing process. The AI-driven product, Franklin, integrates data from published literature and public databases, utilizing machine learning to derive prediction scores and adjust ACMG classification criteria. Genoox's platform is used in the diagnosis and treatment of genetic disorders and cancer, as well as new drug discovery and family planning, aiming to improve patient outcomes with increased accuracy and efficiency, enabling personalized medicine and patient-specific treatments.
Headcount over time
55 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Show all offices (2 more)
- Palo Alto, United States
- New York, United States
Q&A
- What is Genoox's primary business?
- Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations to enhance the accessibility of clinical genetic sequencing.
- When was Genoox acquired and by whom?
- Genoox was acquired by Qiagen in May 2025 for $80 million, which included $70 million in cash and an additional $10 million contingent on achieving milestones.
- Which investor participated in Genoox's B Round in May 2021?
- IN Venture participated in Genoox's B Round in May 2021.
- When was Genoox founded?
- Genoox was founded in March 2014.
- What is the name of Genoox's AI-driven product?
- Genoox's AI-driven product is called Franklin, which integrates data from published literature and public databases to derive prediction scores and adjust ACMG classification criteria.
- What was the total amount raised by Genoox before its acquisition?
- Genoox raised a total of $26 million USD before its acquisition.
Team · 12
Amir Trabelsi
Founder · Co-founder & CEO
Moshe Einhorn
Founder · Co-founder & CTO
Yuval Porat
Founder · CTO
Oron Lev
Founder · COO and Head of Franklin
Ohad Arazi
Chairman of The Board
Guy Harel
Head of Business Operations
Assaf Shefer
VP Product
T. B.
Vice President Delivery
I. B.
Head Of Ux
M. G.
Director Of Product
L. D. C.
Director Of Community
M. L.
Director Of Solutions Management
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine LearningData StorageCloudPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
clinical-trialsdoctorsbig-datagenomicsdigital-healthcaredata-managementdiagnosticsartificial-intelligenceprecision-medicinedata-analyticsdeep-learningcloud-basedpersonalizationhealthcare-providerssoftware-platformcanceractionable-insightspharma-companiesgenetic-disordersmachine-learningdrug-discoveryclinicsdecision-supportbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | genoox.com/ |
|---|---|
| linkedin.com/company/5239418 | |
| facebook.com/genoox |
Identifiers & details
| Founded | 2014-3 |
|---|---|
| Employees (exact) | 55 |
| Offices | Palo Alto; New York |
| Status reason | Acquired by Qiagen on May, 2025 |
Acquisitions & public offerings
Acquired by Qiagen 2025-05 $80.0M
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 9 |
|---|
Web history (Wayback)
| Domain | genoox.com |
|---|
Certificate / subdomain footprint
| Subdomains | 73 |
|---|